openPR Logo
Press release

Hemopet Awarded Key Nutrigenomics Pet Food Patent

11-17-2011 06:56 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Jim Goyjer Associates

/ PR Agency: Jim Goyjer Associates
Hemopet - Pet Life Line

Hemopet - Pet Life Line

A leader in canine health, Hemopet today secured its fourth patent, US Patent 8,060,354, strengthening the company’s already impressive patent portfolio in the field of nutrigenomics. Nutrigenomics essentially involves the design of individualized pet food products. Hemopet’s patent portfolio establishes it as the gatekeeper for nutrigenomic pet food technology in North America.

“Our intellectual property protects and confirms Hemopet as a leader in nutrigenomic pet foods. It validates our being at the forefront of pet food issues and further builds on our philosophy of individualized care for pets.” said Dr. Jean Dodds, President of Hemopet.

This patent is an important addition to Hemopet’s intellectual property portfolio. Hemopet’s business strategy calls for launching nutrigenomic pet food supplements in 2012. These formulas are currently being tested in Europe.

Earlier this year, Hemopet launched Nutriscan www.nutriscan.org, another breakthrough technology for animal diagnostics. This is pet food sensitivity and intolerance diagnostics using saliva and the demand is growing fast. “This testing protocol is also being expanded from the six primary foods to include a total of 20 food antigens commencing in January 2012," says Dodds.

“This is a very exciting time for Hemopet as we lead the way in many areas of pet health. Hemopet’s technology is ground breaking,” said Dodds. “For the first time in veterinary history pets can be diagnosed and treated for food sensitivities on an individual basis. It will simply revolutionize the pet food industry. We consider the dog’s age, breed and size in all our diagnostic technology. Not all dogs are metabolically and genetically alike and our technology provides for individualized care.”

Its newly-patented nutrigenomics pet food patent complements the Nutriscan saliva food sensitivity testing patent. Consumers can obtain more information on NutriScan food sensitivity testing by visiting www.nutriscan.org .

About Hemopet
Founded in 1986 as a non-profit animal blood bank and greyhound rescue/adoption program by Dr. Jean Dodds, Hemopet has expanded its services to include comprehensive animal thyroid testing, and pet food sensitivity and intolerance testing. For more information, visit www.hemopet.org or contact 714-891-2022.

Jim Goyjer Associates
12400 Wilshire Blvd., Suite 200
Los Angeles, CA 90025
Tel: 310-207-1524
Fax: 310-207-1584
Email: jgoyjer@jgapr.com
Web: www.jgapr.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hemopet Awarded Key Nutrigenomics Pet Food Patent here

News-ID: 200887 • Views:

More Releases for Hemopet

Pet Blood Bank Market Set for Robust Growth Through 2033 with Technological Adva …
London, UK - September 2025 | Strategic Revenue Insights Inc. The Pet Blood Bank market is emerging as a pivotal component of modern veterinary healthcare, driven by rising pet ownership and increased awareness of animal welfare. Blood transfusions have become essential for emergency treatments, surgeries, and chronic conditions in pets, underscoring the critical role of blood banking services. The market is projected to reach USD 1.2 billion by 2033,
Pet Blood Bank Market Size, Growth, Forecast 2025-2031 (By Type, By application, …
The global market for Pet Blood Bank was estimated to be worth US$ 262 million in 2024 and is forecast to a readjusted size of US$ 463 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031. 2025 Market Report by QYResearch "Pet Blood Bank - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" provides an extensive examination of Pet Blood Bank market attributes,